Items tagged with Medicines
WHO updates Essential Medicines List (post with simple image)
WHO updates Essential Medicines List with new advice on use of antibiotics and adds medicines for TB.
2017 TAG Pipeline Report (post with simple image)
TAG’s annual Pipeline Report: Promising new HIV, TB & HCV drugs and diagnostics.
TAG's Activist Guides to TB Diagnostics and Treatment now available in Russian (post with simple image)
In collaboration wih the International Treatment Preparedness Coalition, Russia.
USD 31 million saved by GDF through newly-reduced prices for TB medicines (post with simple image)
The Global Drug Facility’s reduced prices are immediately available to all programs, regardless of their procurement funding source, including: national TB programs, governments, non-governmental organizations, and others.
2018 TAG Pipeline Report (post with simple image)
TAG’s annual Pipeline Report: Promising new HIV, TB & HCV drugs and diagnostics.
An Activist’s Guide to Rifapentine (post with simple image)
The guide details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating TB infection in order to prevent active TB disease.
Research, regulatory, and access considerations regarding pretomanid (post with simple image)
TB CAB releases document outlining key considerations regarding pretomanid in anticipation of FDA public advisory committee meeting on the TB Alliance's new drug application for pretomanid.
Public investment in bedaquiline up to five-fold that of Johnson & Johnson (post with simple image)
PLOS ONE publishes TAG’s rigorous, peer-reviewed calculation of investments in the development of this life-saving TB medicine.
Hepatitis C and TB Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access (post with simple image)
Treatment Action Group releases a patent landscape investigating potential patent barriers for the development and delivery of long-acting formulations for selected hepatitis C and TB medicines.
Nitrosamines and TB medicines information note (post with simple image)
TAG and IMPAACT4TB project partners release several materials to explain how the identification of nitrosamines in rifampicin and rifapentine may affect the safety and supply of TB medicines, and what this may mean for TB programs and patients.
Page 18 of 18 · Total posts: 0
←First 17 18